SOURCE: Bellwether Report

June 22, 2006 10:50 ET

Bellwether Report Identifies Small-Cap Gem

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by The Bellwether Report.

VANCOUVER, BC -- (MARKET WIRE) -- June 22, 2006 --BellwetherReport.com is a leading small-cap online financial newsletter which focuses on identifying small-cap emerging growth companies, which have qualities that we look for when deeming a company undervalued. Our research brought to our attention HealthSonix (PINKSHEETS: HSXI), a small-cap multi-dimensional medical technology company that develops and markets healthcare services and FDA registered medical products to treat the pain associated with arthritis; fibromyalgia; soft tissue and muscular injuries. A few other companies we have on our watch list include, CanWest Petroleum (OTCBB: CWPC), Patriot Scientific (OTCBB: PTSC) and Sunwin International Neutraceuticals (OTCBB: SUWN).

Upon completing our due-diligence on HealthSonix it quickly became apparent that the company possessed many of the qualities that we look for when researching aggressive growth companies. Therefore we made the decision to introduce HSXI as our premier small-cap profile of 2006.

Yesterday they announced that one of their products AquaSonix was registered with the United States Food and Drug Administration (FDA). Indications are for pain reduction and muscle relaxation. The device was designated as class 1, the safest classification for medical devices.

Early signs indicate that HealthSonix could be positioned to take advantage of the growing need for alternative treatments, in the fights to combat Arthritis and the pain it causes.

Bellwether Report will continue following HealthSonix Inc (PINKSHEETS: HSXI) over the coming months to gauge the progress they are making. For more information visit www.bellwetherreport.com.

About HealthSonix Inc:

HealthSonix Inc. (PINKSHEETS: HSXI) is a multi-dimensional medical technology company that develops and markets healthcare services and FDA registered medical products to treat the pain associated with arthritis; fibromyalgia; soft tissue and muscular injuries. The company's offerings are based on patent pending medical technologies that use sound pressure waves at the core of its treatment protocols.

Bellwether Report is an online financial newsletter focused on researching small-cap and large-cap public companies. Information has been obtained from sources considered to be reliable, but we do not guarantee that it is accurate or complete. This material is not an offer to sell or a solicitation of an offer to buy any securities. BWR and its affiliates, officers, directors and agents have been compensated to perform research and therefore information should not be construed as unbiased. Each contract varies in duration, services performed and compensation received. BWR is not responsible for any claims made by the Company. You should independently investigate and fully understand all risks before investing. We are not a registered broker-dealer. Before investing in any securities, you should consult with your financial advisor and a registered broker-dealer. Our views and opinions regarding the Company are our own views and are based on information that we have received, which we assumed to be reliable. We do not guarantee that the Company will perform as we expect, and any comparisons we have made to other companies may not be valid or come into effect. Statements included may contain forward-looking statements, including the Company's intentions, forecasts, plans or other matters that haven't yet occurred. Such statements involve a number of risks and uncertainties. Further information on potential factors that may affect, delay or prevent such forward-looking statements from coming to fruition can be found in their specific Financial reports, including the 10-K and 10-Q, which are filed with the Securities and Exchange Commission (SEC). Bellwether Report has been compensated forty thousand shares by a third party for advertising HealthSonix Inc, we have sold zero shares to date.

Contact Information